Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trilostane for Androgen-Independent Prostate Cancer
NCT00181597Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2004
- Primary completion
- Jan 2006
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trilostane in prostate cancer (PCa), sponsored by Sanofi. Started Mar 2004; status: completed.
02
Drugs
trilostane
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00181597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181597.